Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

toothbrush

- PMLiVE

Pfizer gains rights to 3SBio’s investigational bispecific antibody in deal worth over $6bn

The candidate is in clinical development for colorectal cancer, lung cancer and gynaecological tumours

- PMLiVE

Merck’s Welireg granted FDA approval to treat rare tumour types PPGL

Up to 2,000 new cases of pheochromocytoma or paraganglioma are diagnosed in the US every year

- PMLiVE

VML appoints Philippe Huot-Louradour as director of VML Health France

Huot-Louradour most recently served as head of digital strategy at Vivactis Group

Physician talking to elderly patient

Motivations that matter: Understanding clinical trial participation to create better research

Understanding why people join clinical trials is essential to improving recruitment and designing better research. Explores the diverse motivations driving participation — from altruism and hope for better health to...

Cuttsy + Cuttsy

- PMLiVE

The Future of CME in the Virtual World

The future of CME is here—and it’s personal, powerful, and primed for impact. In an era where clinician time is stretched thin, AI and digital innovation are transforming continuing medical...

Medscape Education

- PMLiVE

J&J’s Tremfya approved by MHRA to treat Crohn’s disease and ulcerative colitis

Inflammatory bowel disease is estimated to affect more than 500,000 people in the UK

- PMLiVE

FDA approves Fujirebio’s Lumipulse as first Alzheimer’s disease blood test

The device offers a less invasive option compared to current PET scans and CSF tests

- PMLiVE

Alnylam shares phase 3 results for Amvuttra in rare heart disease ATTR-CM

Transthyretin amyloid cardiomyopathy is estimated to affect over 300,000 people worldwide

- PMLiVE

Stronger Together: Medscape Education Celebrates Accomplishments in Rare Disease and Anticipates the World Health Assembly Adoption of the Resolution on Rare Diseases

Medscape Education is proud to be showcasing the power of working together in rare disease education and advocacy by co-hosting a side event at the 78th World Health Assembly in...

Medscape Education

- PMLiVE

AbbVie and ADARx enter multi-billion dollar partnership to develop siRNA therapies

The companies will focus on developing therapeutics across neuroscience, immunology and oncology

- PMLiVE

Sanofi unveils $20bn US investment to boost R&D and manufacturing presence

The company is the latest major drugmaker to announce a significant investment in the country

- PMLiVE

MSD receives MHRA approval for adult-specific pneumococcal vaccine Capvaxive

Illnesses caused by Streptococcus pneumoniae are currently considered a major public health problem by WHO

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links